Muxscle Decreases Fatigue: Results of a Post Marketing Clinical
Polansky, H., Itzkovitz, E. The Center for the Biology of Chronic Disease, Rochester, NY 14620
Introduction: This paper reports the results of a post marketing clinical study that tested the effect of the dietary supplement
Muxscle on individuals who suffer from excessive fatigue.
Treatment: A capsule of Muxscle includes 100 mg of quercetin, 150 mg of Green Tea Extract, 50 mg of a cinnamomum extract,
25 mg of a licorice extract, and 100 mcg of selenium. The treatment included 1, 2, 3, or 4 capsules per day, and lasted 2 to 54 weeks.
Population: 97 individuals ages 20 to 66, all suffering from excessive fatigue
Results: The participants reported no side effects. Seventy percent of the individuals treated with Muxscle
reported a decrease in their overall level of fatigue (p>0.001, n=93).
The study tested two specific indications of fatigue, the ability to perfrom physical tasks, and the ability to perform mental tasks.
Eighty four percent of the participants reported an increase in one indication or more. Specifically, sixty-seven percent of the individuals treated with Muxscle
reported an increase in their ability to perform physical tasks (p=0.008, n=97) and forty eight percent reported an increase in
their ability to perform mental tasks (p=0.010, n=79). The results showed that Muxscle has a duration effect
(Fatigue - p<0.001, n=70; Physical - p=0.04, n=68; Mental - p=0.12, n=68), that is,
those treated for a longer time reported a larger improvement. The results showed no interviewer bias
(Fatigue - p=0.42, n=97; Physical - p=0.83, n=97; Mental - p=0.90, n=96) and no selection bias.
Conclusions: This post marketing clinical study shows that individuals suffering from excessive fatigue
reported a safe decrease in their level of fatigue following treatment with Muxscle.
Therefore, healthcare practitioners should consider recommending Muxscle to individuals suffering from excessive fatigue.
Note: If you would like to read the full paper, please
send an email to the Center for the Biology of Chronic Disease
(CBCD) requesting a copy.
Click Muxscle to see the
website of the Muxscle product that includes information for the